Physician profile

Michael E Pichichero

Pediatrics · Rochester, NY

NPI 1245337047

$168,155.17

in general payments reported to CMS, 2019-2025

10 companies · $53K in 2025

The $53K reported for 2025 was more than what 99% of Pediatrics providers received nationally (typical 2025 total: $96.93).

See the full distribution for Pediatrics

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$79,725.00
Travel and Lodging$18,477.73
Food and Beverage$316.91

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Glaxosmithkline, LLC. $95,310.08 2021-2025
Merck Sharp & Dohme LLC $20,613.88 2019-2025
Pfizer INC. $17,433.06 2021-2022
Modernatx, INC. $14,350.38 2021-2022
Sanofi Pasteur INC. $11,559.82 2019-2022
Eli Lilly and Company $5,238.68 2025
Astrazeneca Pharmaceuticals LP $3,000.00 2023
Photonicare INC $450.00 2022
Henry Schein, INC. $199.27 2020

1 company reported research payments only; those appear in the research section below.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Michael E Pichichero

$168,155.17

in general payments reported 2019-2025

Years
2019-2025
Top company
Glaxosmithkline, LLC.
Context
The $53K reported for 2025 was more than what 99% of Pediatrics providers received nationally (typical 2025 total: $96.93).

https://glasscript.com/doctor/55779/michael-e-pichichero

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.